Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 160 participants.
Also called NCT05955326
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT05955326
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- India
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05955326. Randomized; quadruple masking; primary purpose treatment. Start 2024-01-08 (actual); primary completion 2026-12-18 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- Condition
- Acute Cerebral Ischemia
- Intervention (Drug)
- Sovateltide
- Intervention (Other)
- Normal Saline
- Lead sponsor
- Pharmazz, Inc.
Record details
- Record id
cardio:ct-nct05955326- Content hash
9cefeb3650f1b3f5ce010cd0e1494a880c0a36f18e71e36c8f43955d6c96b4be